Proteins & Antibodies Sponsors 2014

  • AbSci

    AbSci has developed SoluPro™, a novel proprietary expression system that expedites the drug discovery process while reducing production time and cost. SoluPro™, a bioengineered E.coli expression system, allows the scalable production of soluble recombinant antibodies, enzymes and other proteins without altering their characteristics.

    SoluPro™ streamlines soluble protein expression using high-throughput screening methods, while also eliminating the formation of inclusion bodies. By producing only soluble proteins, SoluPro™ increases yields, eliminates the costly and inefficient refolding process, and decreases production time 50 to 90 percent.

  • Agilent Technologies

    For more than 70 years, Agilent Technologies has been the world’s premier measurement company. Our singular focus on measurement helps scientists and engineers address their toughest challenges with precision and confidence. With the help of our products and services, they are better able to deliver the breakthroughs that make a measurable difference in the world.

    With our liquid and gas chromatographs, mass spectrometers, nuclear magnetic resonance spectrometers, X-ray crystallography instruments and microarrays, researchers characterize proteins and nucleic acids in search of disease markers and to develop breakthrough therapeutics.

    Visit us at

  • Charles River

    Combining the expertise of two long-trusted brands, Charles River pairs Endosafe® rapid endotoxin testing systems with Accugenix® contract microbial identification services to offer a complete QC testing solution. Endosafe® cartridge technology improves operational efficiencies by enhancing ease of use and accelerating testing times. Cost-effective microbial identification is conducted in an FDA-registered lab using the Accugenix® DNA sequence library, which profiles more relevant microorganisms than any other service laboratory in the industry. Whether faced with critical timelines or stringent regulations, you can rely on Charles River to ensure the safe manufacture and timely release of your product. Visit for more information.

  • Chelatec

    Chelatec is a leading contract research organisation (CRO) created in 2000 and providing customized services in the specific fields of radiolabeling and preclinical research. Our mission is to assist the pharmaceutical and biotechnology industry along the drug development process by using the radioactive tracer for Bioanalyses, PharmacoKinetics and ADME studies

    We propose following services: Radioisotopic Labelling

    • Radio-Iodination of Biologicals (antibodies, ADC, proteins, peptides, antigens, ligands)

    • Customized radiolabeling

    • R&D in Nuclear Medicine: Radiopharmaceuticals for Diagnostic and Therapy

    In vitro Evaluation

    • Affinity constants, Inhibition constants

    • Radioimmunoassays

    • Cytotoxicity assays

    In vivo Behaviour

    • Pharmacokinetics, clearance

    • Assessment of animal models

    • Distribution (ADME) in mice or rats from various administration routes SC, IV, IP, oral, nasal

    • Whole Body Autoradiography

  • DNA2.0

    DNA2.0 is the leading bioengineering solutions provider. Founded in 2003, DNA2.0 provides an integrated pipeline of solutions for the research community, including gene design, optimization, synthesis and cloning, as well as platforms for protein and strain engineering. It is the fastest provider of synthetic genes—based in the US with a global customer base encompassing academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. DNA2.0 is by far the most published synthetic gene vendor, providing expert support to and collaboration with scientists. DNA2.0 explores novel applications for synthetic genes and is exploiting the synergy between highly efficient gene design and synthesis processes and new protein optimization technologies. DNA2.0’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline. The company is privately held and is headquartered in Menlo Park, California.

  • Dynamic Biosensors

    Dynamic Biosensors GmbH is a provider of instruments, consumables, and services in the field of analytical systems for the characterization of biomolecules and of molecular interactions. Our offices are located south of Munich (Germany) in Martinsried, a vital center of Europe‘s biotechnology industry. Dynamic Biosensors develops and commercializes the switchSENSE™ technology, a groundbreaking platform technology for the analysis of biomolecules, with applications in R&D and drug development.

  • Eurogentec

    Eurogentec SA is a contract manufacturing organization providing custom products and services to researchers in the research, diagnostic and biopharmaceutical sciences.  The company operates under ISO 9001, ISO 13485 and injectable cGMP quality systems. The close collaboration between Eurogentec’s two business units is Eurogentec’s unique capability to fully support drug development projects from early R&D to commercial phases.

    Headquartered in Belgium and with strategically located subsidiaries worldwide, the Eurogentec Group employs a team of 400 people.

  • Fujifilm Diosynth Biotechnologies

    Fujifilm Diosynth Biotechnologies is an industry leading Biologics Contract Development and Manufacturing Organisation with locations in Billingham, United Kingdom and Research Triangle Park, North Carolina, USA, and between them the two sites have received successful FDA inspections for the manufacture of a total of five commercial products.

    Long recognised as a world leader in the development and manufacture of microbial-derived biologics, the company has significantly expanded its mammalian cell culture capabilities in the last 18 months.  A new mammalian cell culture manufacturing facility was commissioned in October 2013 at the Billingham, UK site, just 18 months after worked commenced. This has been designed primarily to utilise single-use technologies, with the installation of a 1000L single-use bioreactor, and with 2000L bioreactor already planned for 2014 to meet customer demand.  The building includes a mammalian Cell Banking Facility which opened in May 2013.

  • Gyros

    Gyros markets an instrument platform for automating nanoliter-scale bioanalytical immunoassays for toxicology, drug metabolism, and biomarkers. Its Gyrolab platform is based on proprietary compact disc technology, enabling nanoliter miniaturization and workflow automation for results in under an hour. PK: One mouse, one PK profile HCP impurities:  Reduced interference with broad ranges for data driven decision in 1 hour and fewer repeats IgG Quantitation:  Improved reproducibility and broad ranges for expression, clone selection and production Immunogenicity:  Automated workflow with maximized drug tolerance

  • Horiba Scientific

    The HORIBA Group of worldwide companies provides an extensive array of instruments and systems for applications ranging from automotive R&D, process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing and metrology, to a broad range of scientific R&D and QC measurements. Proven quality and trustworthy performance have established widespread confidence in the HORIBA Brand.

    Driven by a desire to bring improvement and benefit to the community, the search for new and innovative ideas is key to HORIBA’s success. With a strong commitment to in-house R&D and a wide range of collaborative ventures with partner companies, there is a constant flow of new products and techniques.

  • Intertek

    Intertek, the leading quality solutions provider, has over 20 years’ experience in GLP immunochemistry, R&D and GMP analytical services for novel biologics including recombinant proteins, peptides, monoclonal antibodies and biosimilars. Our wide range of services have helped clients who are developing or manufacturing biopharmaceuticals to ensure the purity, identity, safety, efficacy and quality of their biologic products at every stage of the development process through to authorization and manufacturing.

  • Malvern Instruments

    Malvern’s technology and expertise supports pharmaceutical and biopharmaceutical research and testing, for better characterization and control of proteins and other biopolymers in solution, as well as the analysis of biological carriers used in drug delivery. The data that Malvern’s instruments provide helps accelerate research and product development, and enhances and safeguards product quality.

  • MaxCyte

    MaxCyte specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of innovative therapeutic products. Drawing on its cell therapy expertise, MaxCyte designed a portfolio of products including the MaxCyte STX® Scalable Transfection System and MaxCyte VLX® Large Scale Transfection System, ideal tools for use in drug discovery research and screening and protein production environments. These products provide for the rapid development and consistent production of billions of (co)transfected primary cells, stem cells, and cell lines for protein and antibody production, for rapid response vaccine development, and for cell-based assays with comparable results and Seamless Scalability™ from the bench to HTS and pilot and production scale.

  • PhyNexus

    Founded in 2002 on the philosophy of applying analytical principles to biological problems, PhyNexus has developed a unique technology that improves and accelerates the drug discovery and drug development processes. The patented PhyTip® column technology applies the unique Tip Concentrating Effect to 96 at-a-time chromatography.  The company provides automated HTP chromatography solution for separating and purifying proteins and plasmid DNA for downstream applications using routine laboratory liquid handling robots. The technology uses standard resins and chemistries including affinity, ion exchange, gel filtration, reverse and normal phases enabling rapid capture, purification and enrichment of protein and nucleic acids.

  • ProBioGen

    ProBioGen is a globally operating, privately held Contract Development & Manufacturing Organization (CDMO) and Technology Provider, focusing on Cell Line and Process Engineering, till GMP Manufacturing of biopharmaceuticals.

    20 years of experience in mammalian cell culture, along with innovative scientific excellence and a strong intellectual property base make ProBioGen a competent and reliable CDMO. All services and technologies are embedded in a total quality management system to assure compliance with international ISO and GMP standards (EMA/FDA).

    ProBioGen was founded 1994 and is located in Berlin, Germany.

    ProBioGen offers State-of-the-Art Services together with Innovative Platform Technologies for optimized biopharmaceutical manufacturing and analysis.

  • Schrodinger

    Schrodinger makes significant investments in R&D, which has led to major advances in the field of computational chemistry. Working closely with its scientific advisory board - a distinguished group of leading academic and industrial scientists who collectively have thousands of publications, many of which represent groundbreaking advances - Schrodinger has achieved breakthroughs in quantum chemistry, molecular modeling, force fields, molecular dynamics, protein structure determination, scoring and virtual screen. Schrodinger's methods development and applications papers have thousands of citations and are often among the most-cited scientific publications. Schrodinger's science is continually validated internally and by its users worldwide.

  • Sigma-Aldrich

    Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing.

    We have customers in life science companies, university and government institutions, hospitals and in industry. Sigma-Aldrich operates in 35 countries and has over 8,000 employees providing excellent service worldwide.

  • TTP Labtech

    TTP Labtech brings 25 years of innovation to the life scientist. It creates automated instrumentation in three product areas; sample management, liquid handling and cell imaging.  These have been developed to improve process efficiencies, minimise assay volumes and optimise workflows.

    TTP Labtech evolved from TTP Group, Europe’s leading independent centre for innovation, and its strength comes from the ability to combine cutting edge science with first rate engineering. The team of passionate, talented and dedicated individuals behind each product and the development of collaborative relationships with the customers differentiate TTP Labtech from other technology based companies.

  • Wacker

    Wacker Biotech is “THE MICROBIAL CMO” – the partner of choice for contract manufacturing of therapeutic proteins using microbial hosts. Our service portfolio covers molecular biology, process and analytical development, and the GMP manufacturing of biologics for clinical trials and commercial supply. Founded in 1999 as a spin-off from the Hans-Knöll Institute in Jena, we are a 100% subsidiary of WACKER Chemie AG since 2005.